Case report: Combinations of immune checkpoint inhibitor, chemotherapy, and hyperthermia therapy avoid lymphatic recurrence in cholangiocarcinoma

被引:0
|
作者
Chang, Heng-Jui [1 ]
Ke, Chiao-Hsu [2 ]
Wang, Yu-Shan [3 ,4 ]
机构
[1] Wesing Surg Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan
[2] Natl Taipei Univ Technol, Inst Chem Engn, Dept Chem Engn & Biotechnol, Taipei, Taiwan
[3] Natl Taiwan Univ, Sch Vet Med, Dept Vet Med, Taipei, Taiwan
[4] Uni Pharm Co Ltd, Taipei, Taiwan
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
immune checkpoint inhibitor; hyperthermia; modulated electro-hyperthermia; cholangiocarcinoma; immunotherapy;
D O I
10.3389/fonc.2024.1421340
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cholangiocarcinoma is a malignancy known for its aggressiveness and limited treatment options. The malignant tumor behaviors include intrahepatic recurrence, regional lymph node (LN) metastasis, peritoneal carcinomatosis, and lung metastasis. Herein, we reported a case of lymphatic recurrence in an intrahepatic cholangiocarcinoma patient after surgery, adjuvant concurrent chemoradiotherapy (CCRT), who experienced a remarkable response to a combination therapy. However, the patient failed to undergo radiotherapy or other invasive local therapy and therefore received Opdivo (nivolumab) in combination with chemotherapy (FOLFOX) and modulated electro-hyperthermia. Notably, after these medical interventions, this patient had a complete response (CR) to treatments, in which no lymph node metastasis occurred, and a significantly decreased tumor marker, CA 19-9, level was found. This case highlights the potential of multiple anti-tumor therapies, including immune checkpoint inhibitors, chemotherapy, and hyperthermia, in managing challenging cholangiocarcinoma cases.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Current advances in immune checkpoint inhibitor combinations with radiation therapy or cryotherapy for breast cancer
    Alice Y. Ho
    Shervin Tabrizi
    Samantha A. Dunn
    Heather L. McArthur
    Breast Cancer Research and Treatment, 2022, 191 : 229 - 241
  • [22] Current advances in immune checkpoint inhibitor combinations with radiation therapy or cryotherapy for breast cancer
    Ho, Alice Y.
    Tabrizi, Shervin
    Dunn, Samantha A.
    McArthur, Heather L.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (02) : 229 - 241
  • [23] IMMUNE CHECKPOINT INHIBITOR-INDUCED THYROIDITIS: CASE REPORT
    Aloyan, T.
    Antonov, E.
    Salimova, D.
    Chandra, G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S105 - S105
  • [24] Rare Presentation of Immune Checkpoint Inhibitor Esophagitis: A Case Report
    Chehade, Nabil El Hage
    Magavi, Pooja
    Wilder, Evan
    Hermes, Joy-Marie
    Lanser, Olivia
    Bao, Fei
    Deabes, Ahmed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2288 - S2289
  • [25] IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOCARDITIS: A CASE REPORT
    Saeed, Mariam
    Khan, Zinobia
    Bachan, Moses
    Raju, Bindu
    Khan, Muneer
    CRITICAL CARE MEDICINE, 2020, 48
  • [26] Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series
    Atieh, Jessica
    Sack, Jordan
    Thomas, Richard
    Rahma, Osama E.
    Camilleri, Michael
    Grover, Shilpa
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (06) : 1974 - 1980
  • [27] RHEUMATIC COMPLICATIONS OF IMMUNE CHECKPOINT INHIBITOR THERAPY: A CASE SERIES
    Moore, Benedict
    Ho, Matthew
    Callan, Margaret
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1031 - 1031
  • [28] Severe cardiotoxicity in 2 patients with thymoma receiving immune checkpoint inhibitor therapy: A case report
    Liu, Shiwei
    Ma, Guikai
    Wang, Hui
    Yu, Guohua
    Chen, Jun
    Song, Wenjing
    MEDICINE, 2022, 101 (46) : E31873
  • [29] Immune checkpoint inhibitor therapy for primary neuroendocrine carcinoma of the gallbladder: A case report and literature review
    Li, Chao
    Lv, Pan
    Liu, Yanyan
    Yin, Maohui
    Li, Hao
    MEDICINE, 2024, 103 (43)
  • [30] Immune checkpoint inhibitor induced colitis and arthritis: A case report
    Xie, Rong-Xin
    Xue, Yu-Bao
    Ci, Xin-Yu
    Zhang, Mei-Juan
    MEDICINE, 2023, 102 (49) : E36334